Drug intelligence / Profile preview

YK-11

Development stage
Preclinical
Lead developer
Yoshimura & Kotera
Modality
Small Molecules
Administration
Oral
01

Overview

YK-11 is a synthetic, steroidal selective androgen receptor modulator (SARM) known for its potent anabolic effects on muscle cells and bone. It functions as a partial agonist of the androgen receptor and also acts as a myostatin inhibitor by increasing the expression of follistatin, a protein that suppresses muscle growth. YK-11 is classified as an experimental compound and has not been approved for medical use in humans. Despite this, it is widely misused in sports as a performance-enhancing drug and is found in dietary supplements. Preclinical studies have investigated its potential in conditions such as muscle wasting, osteoporosis, obesity, and sepsis.

Other names
17α-methyl-δ2-17β-hydroxyestra-4,9-dien-3-one(17α,20E)-17,20-[(1-methoxyethylidene)bis(oxy)]-3-oxo-19-norpregna-4,20-diene-21-carboxylic acid methyl ester
02

Targets

AR (Adrenergic receptors)

Beyond the preview

Go deeper on YK-11.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on YK-11.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call